
CPESN USA announces the recipients of its 2025 CPESN Most Engaged Pharmacy Awards and recognizes 32 pharmacies from across America.
CPESN USA announces the recipients of its 2025 CPESN Most Engaged Pharmacy Awards and recognizes 32 pharmacies from across America.
Patients with a single cardiometabolic disease have an approximately 48% greater risk of developing all-cause dementia than those without a cardiometabolic disease.
Researchers explored the effectiveness of telephonic insulin titration by a clinical pharmacist compared with in-office titration among patients in a medical residency clinic.
Brett Barker, PharmD, state representative in Iowa’s 51st District, joined Drug Topics to discuss significant implications and common misconceptions regarding Iowa’s new PBM bill.
Efsitora demonstrates noninferior reductions in hemoglobin A1c and similar rates in patients with an A1c level less than 7% compared with common daily insulin.
The therapy is now the first and only oral on-demand treatment option for the condition.
Researchers determined the impact COVID-19 interventions had on Danish children’s incidence of RSV, influenza, and invasive pneumococcal disease.
This year’s conference is taking place from July 10 to 13 in Nashville, Tennessee.
Investigators also report that sodium-glucose cotransporter 2 inhibitors are not associated with thrombotic risk.
Health care professionals emphasize patient education and reliable information in the evolving vaccine recommendation landscape.
Kevin W. Cleveland, PharmD, urges evidence-based approaches to immunizations in an era of uncertainty.
Patients who used the Bigfoot Unity Diabetes Management System had glycemic control and reduced diabetes distress.
Cherokee Layson-Wolf, PharmD, BCACP, FAPhA, discusses the impact of shifting guidance on vaccination strategies.
As concerns mount over potential shifts in vaccine recommendations, Deanna Tran, PharmD, BCACP, FAPhA, advocates for rigorous data assessment and patient-centered communication strategies.
In part 3 of our interview with Walgreens Chief Pharmacy Officer Rick Gates, he explores the future of pharmacy practices and how modern use of technologies like AI are becoming commonplace.
Researchers explored patients with type 1 diabetes and overweight or obesity to understand the efficacy and safety of GLP-1s as adjunctive therapies.
In a recap of his presentation at the American Diabetes Association’s 85th Scientific Sessions, Jon Easter, RPh, discussed the role of pharmacists in team-based diabetes care.
Taylor Watterson, PharmD, PhD, discusses how pharmacy technician burnout can impact pharmacy operations.
Rob Frankil, RPh, discusses how independent pharmacies in Pennsylvania are dealing with the impact of Rite Aid stores closing.
Pharmacist-led deprescribing can help reduce the number of medications a patient is taking in an effective way.
Interest in community pharmacy practice is declining as pharmacists seek roles with better work-life balance, greater autonomy, and more meaningful patient care opportunities.
In an abstract presented at the American Diabetes Association 85th Scientific Sessions, researchers tested the effectiveness of an AI-driven program for improving glycemic control.
Pharmacists play a role in educating patients as well as making them feel more comfortable when utilizing opioid use treatment.
Rick Gates, chief pharmacy officer at Walgreens and chairman of the National Association of Chain Drug Stores, discussed the current status of retail pharmacies and the way they are reimbursed.
Pharmacists play a key role in medication for abortion care by providing clinical guidance, patient counseling, and advocacy.
Of those who do not support vaccines, 79% said a major reason for their opposition is that it should be the parents’ choice about whether to vaccinate their child, and 40% cite safety concerns.
Clinical pharmacists transform diabetes care by leveraging manufacturer-sponsored patient assistance programs to dramatically improve medication access.
An ambulatory care pharmacist program in Washington State dramatically improved diabetes management by reducing A1c levels, increasing medication adherence, and providing comprehensive patient education.
ACIP also discusses COVID-19 epidemiology as well as safety and efficacy for the COVID-19 vaccines.